Abstract
Cannabigerol(3) was synthesized and evaluated for its inhibitory activity against mouse skin melanoma cells. Cannabigerol displayed significant antitumor activity [inhibitory concentration (IC50)=31.3l μ/mL]in vitro assay.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References Cited
Baek, S. H., Yook, C. N. and Han, D. S.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent(V). A convenient single step synthesis of cannabinoids.Bull. Kor. Chem. Soc. 16(3), 293–296 (1991).
Baek, S. H., Srebnik, M., and Mechoulam, R.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent. An improved synthesis of cannabidiol.Tetrahedron Lett. 26(8), 1083–1086 (1985).
Baik, K. U., and Ahn, B. Z.: Cyctotoxic activities of some geranylated flavones against L 1210 cell.J. Pharm. Soc. Korea, 32(2), 125–128 (1988).
colasanti, B. K., and Gong, H., Marihuana 87, Chesher, G.; Consroe, P.; Musty, R. Ed., Australian Government Publishing Service, Canberra, pp. 119–124 (1988).
Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing.Cancer Res. 47, 936–942 (1987).
Dewey, W. L.: Cannabinoid pharmacology.Pharmacol. Rev., 38, 151–178 (1986).
Kleinman, S., Weitzman, S. A., Cassem, N., and Andrews, E.: Double blind trial of δ-9-tetrahydrocannabinol (THC) as an adjunct to prochlorperazine for chemotherapy-induced vomiting.Curr. Ther. Res. 34, 1014–1017 (1983).
Kang, K. S., Ryu, S. H., and Ahn, B. Z.: Antineoplastic natural products and the analogues VI.Arch. Pharm. Res. 8, 187–190 (1985).
Mechoulam, R.: In Cannabinoids as therapeutic agents, Boca Raton, CRC Press Inc., (1986).
Mosmann, T. J.:Rapid colorimetric assays for cellular growth and survival: application to proliferation and cytotoxicity assays.Immunol. Methods, 65, 55–63 (1983).
McCabe, M., Smith, F. P., Macdonald, J. S., and Woolley, P. V.:Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.Invest. New Drugs. 6, 243–246 (1988).
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., and Wadleig, H. R. G.: Recent clinical experince with dronabinol.Pharmacol. Biochem. Behav. 40, 695–700 (1991).
Sallan, S. E., Cronin, C., Zelen, M., and Zinberg, N. E.: Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of δ-9-tetrahydrocannabinol and prochlorperazine.N. Engl. J. Med. 302, 135–138 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baek, SH., Du Han, S., Yook, C.N. et al. Synthesis and antitumor activity of cannabigerol. Arch. Pharm. Res. 19, 228–230 (1996). https://doi.org/10.1007/BF02976895
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976895